Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes

@inproceedings{Feinkohl2013ClinicalAS,
  title={Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes},
  author={Insa Feinkohl and Mark{\'e}ta Keller and Christine M. Robertson and J R Morling and Rachel M. Williamson and Lisa D. Nee and Stela McLachlan and Naveed Sattar and Paul Welsh and Rebecca M. Reynolds and Tom C Russ and Ian J. Deary and Mark W. J. Strachan and Jackie F. Price},
  booktitle={Diabetes care},
  year={2013}
}
OBJECTIVE Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes. RESEARCH DESIGN AND METHODS Eight hundred thirty-one men and women (aged 60-75 years) attended two waves of the prospective Edinburgh Type 2 Diabetes Study (ET2DS). At baseline, clinical and subclinical… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS